European symposium on precision medicine in allergy and airways diseases: report of the European Union parliament symposium (October 14, 2015)

A Muraro, W J Fokkens, S Pietikainen, D Borrelli, I Agache, J Bousquet, V Costigliola, G Joos, V J Lund, L K Poulsen, D Price, C Rolland, T Zuberbier, P W Hellings

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

On 14 October 2015, the European Academy of Allergy and Clinical Immunology (EAACI), the European Rhinologic Society (ERS) and the European Medical Association (EMA) organized a symposium in the European Parliament in Brussels on Precision Medicine in Allergy and Airways Diseases, hosted by MEP David Borrelli and with active participation of the European Respiratory Society (ERS), the European Federations of Allergy and Airways Diseases Patients Associations (EFA), the Global Allergy and Asthma European Network (Ga2len), Allergic Rhinitis and Its Impact on Asthma (ARIA) and the Respiratory Effectiveness Group (REG). MEP Sirpa Pietikainen, Chair of the European Parliament Interest Group on Allergy and Asthma, underlined the importance of the need for a better diagnostic and therapeutic approach for patients with Allergies and Chronic Airways Diseases, and encouraged a joint initiative to control the epidemic of Allergy and Asthma in Europe. The socio-economic impact of allergies and chronic airways diseases cannot be underestimated, as they represent the most frequently diagnosed chronic non-communicable diseases in the EU. Despite the fact that 30% of the total European population is nowadays suffering from allergies and asthma, more than half of these patients are deprived from adequate diagnosis and treatment. Precision Medicine represents a novel approach in medicine, embracing 4 key features: personalized care based on molecular, immunologic and functional endotyping of the disease, with participation of the patient in the decision making process of therapeutic actions, and taking into account predictive and preventive aspects of the treatment. Implementation of Precision Medicine into clinical practice may help to achieve the arrest of the Epidemic of Allergies and Chronic Airways Diseases. This report summarizes the key messages delivered during the symposium by the speakers, including the EU Commissioner for Health and Food Safety Vitenys Andriukaitis. The Commissioner underscored the need for optimal patient care in Europe, supporting joint action plans for disease prevention, patient empowerment and cost-effective treatment strategies leading to a better health status of European citizens.

Original languageEnglish
Pages (from-to)303-307
Number of pages5
JournalAmerican Journal of Rhinology
Volume53
Issue number4
DOIs
Publication statusPublished - Dec 2015

Fingerprint

Precision Medicine
European Union
Hypersensitivity
Asthma
Patient Participation
Chronic Disease
Public Opinion
Food Safety
Therapeutics
Allergy and Immunology
Health Care Costs
Health Status
Decision Making
Patient Care
Economics
Medicine

Keywords

  • Europe
  • Humans
  • Hypersensitivity
  • Precision Medicine
  • Respiratory Tract Diseases
  • Congresses

Cite this

European symposium on precision medicine in allergy and airways diseases : report of the European Union parliament symposium (October 14, 2015). / Muraro, A; Fokkens, W J; Pietikainen, S; Borrelli, D; Agache, I; Bousquet, J; Costigliola, V; Joos, G; Lund, V J; Poulsen, L K; Price, D; Rolland, C; Zuberbier, T; Hellings, P W.

In: American Journal of Rhinology, Vol. 53, No. 4, 12.2015, p. 303-307.

Research output: Contribution to journalArticle

Muraro, A, Fokkens, WJ, Pietikainen, S, Borrelli, D, Agache, I, Bousquet, J, Costigliola, V, Joos, G, Lund, VJ, Poulsen, LK, Price, D, Rolland, C, Zuberbier, T & Hellings, PW 2015, 'European symposium on precision medicine in allergy and airways diseases: report of the European Union parliament symposium (October 14, 2015)', American Journal of Rhinology, vol. 53, no. 4, pp. 303-307. https://doi.org/10.4193/Rhin15.400
Muraro, A ; Fokkens, W J ; Pietikainen, S ; Borrelli, D ; Agache, I ; Bousquet, J ; Costigliola, V ; Joos, G ; Lund, V J ; Poulsen, L K ; Price, D ; Rolland, C ; Zuberbier, T ; Hellings, P W. / European symposium on precision medicine in allergy and airways diseases : report of the European Union parliament symposium (October 14, 2015). In: American Journal of Rhinology. 2015 ; Vol. 53, No. 4. pp. 303-307.
@article{36b664e9d75f42aa96b621b98cc51edf,
title = "European symposium on precision medicine in allergy and airways diseases: report of the European Union parliament symposium (October 14, 2015)",
abstract = "On 14 October 2015, the European Academy of Allergy and Clinical Immunology (EAACI), the European Rhinologic Society (ERS) and the European Medical Association (EMA) organized a symposium in the European Parliament in Brussels on Precision Medicine in Allergy and Airways Diseases, hosted by MEP David Borrelli and with active participation of the European Respiratory Society (ERS), the European Federations of Allergy and Airways Diseases Patients Associations (EFA), the Global Allergy and Asthma European Network (Ga2len), Allergic Rhinitis and Its Impact on Asthma (ARIA) and the Respiratory Effectiveness Group (REG). MEP Sirpa Pietikainen, Chair of the European Parliament Interest Group on Allergy and Asthma, underlined the importance of the need for a better diagnostic and therapeutic approach for patients with Allergies and Chronic Airways Diseases, and encouraged a joint initiative to control the epidemic of Allergy and Asthma in Europe. The socio-economic impact of allergies and chronic airways diseases cannot be underestimated, as they represent the most frequently diagnosed chronic non-communicable diseases in the EU. Despite the fact that 30{\%} of the total European population is nowadays suffering from allergies and asthma, more than half of these patients are deprived from adequate diagnosis and treatment. Precision Medicine represents a novel approach in medicine, embracing 4 key features: personalized care based on molecular, immunologic and functional endotyping of the disease, with participation of the patient in the decision making process of therapeutic actions, and taking into account predictive and preventive aspects of the treatment. Implementation of Precision Medicine into clinical practice may help to achieve the arrest of the Epidemic of Allergies and Chronic Airways Diseases. This report summarizes the key messages delivered during the symposium by the speakers, including the EU Commissioner for Health and Food Safety Vitenys Andriukaitis. The Commissioner underscored the need for optimal patient care in Europe, supporting joint action plans for disease prevention, patient empowerment and cost-effective treatment strategies leading to a better health status of European citizens.",
keywords = "Europe, Humans, Hypersensitivity, Precision Medicine, Respiratory Tract Diseases, Congresses",
author = "A Muraro and Fokkens, {W J} and S Pietikainen and D Borrelli and I Agache and J Bousquet and V Costigliola and G Joos and Lund, {V J} and Poulsen, {L K} and D Price and C Rolland and T Zuberbier and Hellings, {P W}",
year = "2015",
month = "12",
doi = "10.4193/Rhin15.400",
language = "English",
volume = "53",
pages = "303--307",
journal = "American Journal of Rhinology",
issn = "1050-6586",
publisher = "OceanSide Publications Inc.",
number = "4",

}

TY - JOUR

T1 - European symposium on precision medicine in allergy and airways diseases

T2 - report of the European Union parliament symposium (October 14, 2015)

AU - Muraro, A

AU - Fokkens, W J

AU - Pietikainen, S

AU - Borrelli, D

AU - Agache, I

AU - Bousquet, J

AU - Costigliola, V

AU - Joos, G

AU - Lund, V J

AU - Poulsen, L K

AU - Price, D

AU - Rolland, C

AU - Zuberbier, T

AU - Hellings, P W

PY - 2015/12

Y1 - 2015/12

N2 - On 14 October 2015, the European Academy of Allergy and Clinical Immunology (EAACI), the European Rhinologic Society (ERS) and the European Medical Association (EMA) organized a symposium in the European Parliament in Brussels on Precision Medicine in Allergy and Airways Diseases, hosted by MEP David Borrelli and with active participation of the European Respiratory Society (ERS), the European Federations of Allergy and Airways Diseases Patients Associations (EFA), the Global Allergy and Asthma European Network (Ga2len), Allergic Rhinitis and Its Impact on Asthma (ARIA) and the Respiratory Effectiveness Group (REG). MEP Sirpa Pietikainen, Chair of the European Parliament Interest Group on Allergy and Asthma, underlined the importance of the need for a better diagnostic and therapeutic approach for patients with Allergies and Chronic Airways Diseases, and encouraged a joint initiative to control the epidemic of Allergy and Asthma in Europe. The socio-economic impact of allergies and chronic airways diseases cannot be underestimated, as they represent the most frequently diagnosed chronic non-communicable diseases in the EU. Despite the fact that 30% of the total European population is nowadays suffering from allergies and asthma, more than half of these patients are deprived from adequate diagnosis and treatment. Precision Medicine represents a novel approach in medicine, embracing 4 key features: personalized care based on molecular, immunologic and functional endotyping of the disease, with participation of the patient in the decision making process of therapeutic actions, and taking into account predictive and preventive aspects of the treatment. Implementation of Precision Medicine into clinical practice may help to achieve the arrest of the Epidemic of Allergies and Chronic Airways Diseases. This report summarizes the key messages delivered during the symposium by the speakers, including the EU Commissioner for Health and Food Safety Vitenys Andriukaitis. The Commissioner underscored the need for optimal patient care in Europe, supporting joint action plans for disease prevention, patient empowerment and cost-effective treatment strategies leading to a better health status of European citizens.

AB - On 14 October 2015, the European Academy of Allergy and Clinical Immunology (EAACI), the European Rhinologic Society (ERS) and the European Medical Association (EMA) organized a symposium in the European Parliament in Brussels on Precision Medicine in Allergy and Airways Diseases, hosted by MEP David Borrelli and with active participation of the European Respiratory Society (ERS), the European Federations of Allergy and Airways Diseases Patients Associations (EFA), the Global Allergy and Asthma European Network (Ga2len), Allergic Rhinitis and Its Impact on Asthma (ARIA) and the Respiratory Effectiveness Group (REG). MEP Sirpa Pietikainen, Chair of the European Parliament Interest Group on Allergy and Asthma, underlined the importance of the need for a better diagnostic and therapeutic approach for patients with Allergies and Chronic Airways Diseases, and encouraged a joint initiative to control the epidemic of Allergy and Asthma in Europe. The socio-economic impact of allergies and chronic airways diseases cannot be underestimated, as they represent the most frequently diagnosed chronic non-communicable diseases in the EU. Despite the fact that 30% of the total European population is nowadays suffering from allergies and asthma, more than half of these patients are deprived from adequate diagnosis and treatment. Precision Medicine represents a novel approach in medicine, embracing 4 key features: personalized care based on molecular, immunologic and functional endotyping of the disease, with participation of the patient in the decision making process of therapeutic actions, and taking into account predictive and preventive aspects of the treatment. Implementation of Precision Medicine into clinical practice may help to achieve the arrest of the Epidemic of Allergies and Chronic Airways Diseases. This report summarizes the key messages delivered during the symposium by the speakers, including the EU Commissioner for Health and Food Safety Vitenys Andriukaitis. The Commissioner underscored the need for optimal patient care in Europe, supporting joint action plans for disease prevention, patient empowerment and cost-effective treatment strategies leading to a better health status of European citizens.

KW - Europe

KW - Humans

KW - Hypersensitivity

KW - Precision Medicine

KW - Respiratory Tract Diseases

KW - Congresses

U2 - 10.4193/Rhin15.400

DO - 10.4193/Rhin15.400

M3 - Article

C2 - 26688860

VL - 53

SP - 303

EP - 307

JO - American Journal of Rhinology

JF - American Journal of Rhinology

SN - 1050-6586

IS - 4

ER -